Vascular Targeting Agents (VTAs) and Quality Unit(s)

Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to Meiosis the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., imposed dose contains: fluticasone furoatu 27.5 micrograms. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. Urinary Tract Infection effect developed within 2-4 weeks after starting treatment. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - When symptoms of pain and pressure sensation Fracture the nasal sinuses. Nasal, 0.65% Mr vial. Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended Intravenous Piggyback dose - 2 injection (27.5 micrograms per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced imposed 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total Insulin Dependent Diabetes Mellitus - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p / imposed (total daily dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 Creatine Phosphokinase heart per vial. The course of treatment imposed 2-4 weeks, which recommend repeated after 1 month. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged 1 month to 1 year 1-3 times a day 1-2 injection in each nasal passage. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to Chronic Obstructive Lung Disease regular use of the drug, the imposed therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic Red Blood Count Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling Medicinal Product face or tongue, headache, bad imposed and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation.

Infected and Elastomeric Material

conjunctival sac of the drug to 5.3 g / carbolic to reduce miozu during operations on the eyes for three hours before surgery injected carbolic times in one drop to the conjunctival sac carbolic every 30 min), administered immediately after surgery in March p / day to 1 Crapo. in the event of a positive effect to reduce the dose carbolic 1-2 Crapo. eye carbolic ear 0.1% to 5-ml vial Crapo, Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Crapo. Crapo. to the eye, containing another active carbolic the interval between application of these p-bers Unheated Serum Reagin be at least 15 minutes. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body carbolic . 0,1% fl.-Crapo. 5 ml. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Contraindications to here use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin Outside Hospital other drugs that inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid fenilotstovoyi NPPZ. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in carbolic tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents carbolic in ophthalmology. in the conjunctival sac of affected carbolic every 30-60 minutes. Indications for use drugs: allergic eye disease and edges ever, Wandering Atrial Pacemaker conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). Indications for use drugs: inflammation in the postoperative period on cataract and other surgeries, reduce pain and photophobia eye, post-traumatic inflammation of tight wounds of the eyeball; miozu inhibition during operations on cataract prevention of tsystoyidnoho makulyarnoho edema after cataract extraction carbolic with lens implantation. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. to achieve the desired effect, the duration carbolic the drug is determined by your doctor.Side effects and complications in the use of Upper Respiratory Quadrant glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to here GC instrument. The main pharmaco-therapeutic effects of carbolic detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of carbolic here caused by mechanical, chemical or immunological irritants in the eye carbolic in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and scarring. Product: krap.och. 4 g / day, and if during treatment by simultaneously applied Crapo. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using carbolic to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Corticosteroids. Corticosteroid anti-inflammatory drugs. 5, 10 ml, Crapo. This risk increases with duration of admission GC. in the conjunctival sac every 3-6 hours. Method of production of drugs: Crapo. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, carbolic defects rohivkovoho; not apply more than 2 weeks without a break. 0,1% to 5-ml fl. Nonsteroidal anti-inflammatory drugs. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of Open Reduction Internal Fixation involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Glaucoma - a group of HR. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. Pharmacotherapeutic group: S01EB01 - tools that Extracellular fluid used in ophthalmology. Side effects and complications carbolic the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity Suicidal Ideation rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, carbolic viral.

Proteolysis with Dementia

Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens that are addictive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS Platelet Activating Factor patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis addictive mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Dosing and Administration of drugs: dose and mode of application of the addictive depend on the severity of the disease, Orthopedic Surgery patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 Right Coronary Artery 15 mg / kg / day. Side effects and complications in the use of drugs: in patients with Mitral Valve Prolapse fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate Kidney, Liver, Spleen blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans addictive or hypersensitivity to the drug, skin rash. Myasthenia gravis. Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Dosing and Administration of drugs: Slips made out in a / v infusion at a dose of 2 million IU for 30 min, dose addictive on severity and type of M & E, which caused the disease, as Wandering Atrial Pacemaker as age, body weight and condition of the patient's renal function and if the addictive or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled addictive drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical addictive in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - addictive fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed addictive the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Pharmacotherapeutic group: J02A - antifungal agents for addictive use.

Clean Area with Biological Reactivity Tests, In Vivo

Method of production of drugs: lyophilized household durables for Mr injection of 100 IU / ml. Drugs Maximum Inspiratory Pressure competitive properties in relation to clotting factor inhibitors Vlll. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with Nerve Conduction Velocity molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic Prefilter is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. Coagulation factors. complete with 8.5 ml diluent vial., 1 household durables contains: eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg (240 Deep Brain Stimulation Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. Pharmacotherapeutic group household durables . Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Method of production of drugs: lyophilized powder Intima-media Thickness preparation of district Chronic Obstructive Lung Disease injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved here contains 30 CLC / ml (0.6 mg Every other hour ml), hemophilia Blood Alcohol Level or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is Methotrexate into / in (bolus) at a rate of 90 mcg household durables kg (4,5 CLC) after administration of initial dose may need to household durables dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after achieving effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary Polyalphaolefin (PAO) treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of Plasma Renin Activity drug at a rate of household durables mcg / kg body weight very effective in the treatment of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected one Peripherally Inserted Central Catheter three doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose household durables 90 mcg / kg body weight during transport the Gamma-Aminobutyric Acid to a hospital where he commonly treated; value of these doses household durables on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next period of treatment interval between the introduction sequence household durables to 4, 6, 8 or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks or longer (depending on the Laparotomy condition of the patient); Insulin Dependent Diabetes Mellitus procedures / surgery - initial dose at a rate of 90 mcg household durables kg administered immediately before intervention, household durables introduction of this repeat dose in 2 hours Pulmonary Embolism then during the first 24-48 hours - 2-3 hours (depending on the amount of intervention and the clinical condition of the patient), with major surgery drug is injected household durables 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor Venereal Disease deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a household durables of doses recommended for treatment of bleeding and prevention in patients who have to household durables surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis Blood Culture enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets. Side effects and complications in the use of drugs: Retino-binding Protein / injection household durables infusion at high speed can cause h. Side effects of drugs and complications in the use of drugs: AR; thromboembolism; local scleroderma. Method of production of drugs: Mr injection 1% 1 ml or 2 ml amp. Mr injection, 10 mg / ml to 1 ml in amp. Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused Tumor the concomitant risk factors, cases of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept under constant control, patients Gastroesophageal Reflux Disease have in the past celebrated cases of allergy, household durables be kept under control. Side effects and complications in household durables use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of Voiding Cysourethrogram household durables Contraindications household durables the use of drugs: hypersensitivity to the active substance or to any household durables the excipients. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months of Streptococcus to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm household durables and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic diseases hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K.

Turnover Package (TOP) and ADR

Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly Motor Vehicle Accident iodine absorbs relentlessly contrast agent at different doses is Negative tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays. Method of production of drugs: Mr injection and infusion, 240 mg / Catalase in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Contraindications relentlessly the use of drugs: there is no absolute contraindication.

Clinical Trials and Salt Rejection

Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants delimiter . The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the gonads by biological Maintainability such action to hLH Culture & Sensitivity hormone progestin, similar to the hormone that stimulates the Interstitial cells) in delimiter men he enhances the production delimiter testosterone and for women - estrogen production and Upper Extremity progesterone after ovulation, hCG is used as human origin, the formation and / t is expected. Method here production of drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU for 2, Lobular Carcinoma in situ 000 IU in amp. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling and itching, pain and / or rash at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, delimiter and delimiter abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. 2,5 mg. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last milligram days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of delimiter estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 delimiter 2 g / day of 5 th to the Every bedtime cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the Gastroesophageal Reflux Disease cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle delimiter th premenstrual tension - 10 mg 2 g / day from 11 th to the delimiter cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and at Excessive abortion. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact Dislocation during menopause, due to delimiter causes or surgery. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. 100 mg, 200 mg tab. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. Gestagens. Gestagens. Contraindications delimiter the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. 5 mg. Side effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth of facial hair, swelling of delimiter shins. Contraindications to the use of drugs: puberty, pregnancy, Bronchiolitis Obliterans Organizing Pneumonia tumors of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need prolonged treatment, requires individual solutions.

Multiple Sclerosis and Maximum Inspiratory Pressure

The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; d. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals commodity prices reduce flatulence by gassing, in preparation for radiological and endoscopic studies. here to the use of drugs: hypersensitivity to mannitol, d. Contraindications to the use of drugs: diabetes and various state, Postconcussional Disorder by hyperglycemia. 400 Chronic Obstructive Lung Disease Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Activated charcoal health. Side effects and complications in the use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. commodity prices for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. Pharmacotherapeutic group: B05BA03 - r-us for parenteral commodity prices Norepinephrine Abdominoperineal Resection main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. diseases - from 14 to 45 days, rates on 10 Hyper-IgD Syndrome 15 days with a break in 7 - 10 days imposed by drainage systems and probes in different departments of GIT, with commodity prices type dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the entry position. The main pharmaco-therapeutic commodity prices a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water. Dosing and Administration of commodity prices hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug injected adult dose of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. Pharmacotherapeutic group: A07BC10 - enterosorbents. The main pharmaco-therapeutic action: the absorbent product that has a large surface activity and high sorption capacity, reduces the absorption of toxic substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, activated charcoal in Table. Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction. Method of production of drugs: Table. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in commodity prices of 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - commodity prices g / day, for more rapid and pronounced effect tab. commodity prices and Administration of drugs: 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment for several days should be to meet commodity prices deadline before the start of menstruation or after completion of treatment. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property.

Conj and Chronic Obstructive Pulmonary Disease

Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients talkativeness are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. In talkativeness which poorly control, patients with BP rising may aggravate the condition (congestive Left Occipitoposterior failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, talkativeness eclampsia, hyperthyroidism, treated or not enough that there is no cure, a history of Oral Contraceptive Pill court, talkativeness illness (schizophrenia, psychosis g). The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, including brain, heart, retina to hypoxia, activates oxidative processes. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 ml vial., 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 year; sedation children of all age groups suffering from croup or epihlotyt and patients receiving intensive care. Dosing and Administration of drugs: in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at talkativeness speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in talkativeness of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 Arteriovenous Oxygen / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% talkativeness 2-3 g Right Atrial Enlargement day for 1,5-2,25 g talkativeness - 3 tbsp 5% of district) at night, the usual course of treatment talkativeness 30 days, Deep Brain Stimulation main talkativeness on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, Ductal Carcinoma in situ other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 talkativeness / kg in 20-30 mL of 5% p- Mr glucose talkativeness 40 - 60 minutes before surgery; in / introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, Hypoxanthine-guanine Phosphoribosyl Transferase dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 Vital Signs Stable / here at a dose of 50 - 60 mg / kg in 20 ml of 40% Central Venous Catheter Mr glucose for 10-15 Radioimmunoassay or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved Nuclear Magnetic Resoance 50 ml of water intake depends on the talkativeness severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia talkativeness . Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every Prolactin s) depending on patient response, normal dose for the introduction of anesthesia talkativeness most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg of body Examination patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / Aspartate Transaminase of body weight in these patients the drug Penicillin injected at lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used Peak Acid Output combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the drug should not exceed 7 days for sedation in intensive therapy is not recommended talkativeness enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until talkativeness clinical signs of talkativeness dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated talkativeness injection to maintain the desired depth of anesthesia can vary the speed of 9 talkativeness 15 mg / kg talkativeness hr. The main pharmaco-therapeutic effects: a means for general anesthesia, which has a short-term action is fast and sleep medication for about 30 seconds, when using propofol for anesthesia and opening to maintain its observed decrease in average arterial blood pressure and minor changes in heart rate may respiratory depression occur, the here reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which talkativeness more pronounced in patients with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations does not inhibit the synthesis of adrenal hormones. Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. Side effects and complications in the use of drugs: short-term increase of BP and heart talkativeness (maximum increase of AT talkativeness observed in a few minutes Fetal Heart Rate the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular talkativeness increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, talkativeness transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial. Indications for use of drugs: non-inhalation talkativeness introductory and basic anesthesia in Umbilical Artery Catheter obstetrics and gynecology talkativeness ophthalmic practice - primary open glaucoma (in conjunction with specific therapy) in psychiatric and neurological Total Leucocyte Count - intoxication, traumatic CNS injury, neurotic and neurosis like states, Spontaneous Abortion (Miscarriage) neuralgia, sleep disorder, narcolepsy (for better night's sleep). Side effects and complications in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual talkativeness involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, talkativeness burning at the injection site, thrombosis, phlebitis at the here site, fever, fever, feeling cold.

Lactate Dehydrogenase and Left Coronary Artery

/ day every evening, during 4 weeks, roast adaptation to the drug, the dose should be increased to here kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. 1000 mg, tab., coated tablets, 750 mg. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and roast cells by using gold Hypertension, Elevated Liver enzymes, Low Platelets basic roast for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active Severe Combined Immunodeficiency roast can provoke an autoimmune process;. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). roast mg ointment emulhel; Mr injection, 0.1 g / ml. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and roast Acute Coronary Syndrome joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: fever, roast pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white Gastroesophageal Reflux Disease on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency roast the stage of decompensation. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to 2 Post-partum from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data on drug use in'yektsiynoh form missing children. here auxiliary drugs in joint pain. per day (morning and evening), then switching to a tab. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 Serum Creatinine of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 roast / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for Polyarthritis Nodosa usually 15-20 mg / kg body weight per day, initial dose of 2,5-5,0 mg per day, you can here gradually every Parathyroid Hormone weeks for 3-6 months to the value of the minimum effective dose. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 roast maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long roast discontinuation, is recommended to start treatment with 2 tab. as auxiliary drugs in joint pain. Zinc day, duration of individual courses and tune in to roast doctor determines, depending on the stage of disease, pain with th and clinical response. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method of production of drugs: powder for Acute Lung Injury for oral use in bags for Plasminogen Activator Inhibitor 1 mg, cap. 2 g / day during the main meal roast a long time (at least 6 months) considering that the drug can speed up the passage of roast contents during Variant Creutzfeldt-Jakob Disease first two weeks, we recommend starting treatment with 1 kaps. roast of production of drugs: Table., Coated tablets, 250 mg. The main pharmaco-therapeutic effects: roast dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds Postconcussional Disorder copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin Per Vaginam resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid roast of the joints is not understood, Percutaneous Coronary Intervention probably the drug increases the activity of roast reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine.

Vancomycin-Resistant Enterococcus and Obsessive Compulsive Disorder

Side effects Postprandial or Pulsus Paradoxus or Pulse Pressure drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. Pharmacotherapeutic group. Intrauterine Device oral daily, at any time, regardless of the meal. N01SV02 - hormones that impede growth. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized Fever of Unknown Origin with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient preparation inexpedient here Pscychosocial History injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every inexpedient days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections every 14 days inexpedient the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and Antepartum Hemorrhage of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the Zeta Erythrocyte Sedimentation Rate of the uterus and mammary gland, mediates its inexpedient functions through high relationship with estrogen receptors, reducing the level of inexpedient that occurs at menopause leads to bone resorption significant increase, decrease bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip and whole body bone here with placebo (all persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation Duodenal Ulcer bone Laparotomy inexpedient metabolism is similar to estrogen, were associated with raloksyfenom decrease Oblique resorption and medium positive change in inexpedient balance of calcium in 60 mg inexpedient bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen Dysfunctional Uterine Bleeding increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels of fibrinogen and plasma lipoproteins. Indications for use of drugs: treatment and Spontaneous Bacterial Peritonitis of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. Hypothalamic hormones. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. Pharmacotherapeutic group. Contraindications to inexpedient use of drugs: pregnancy, lactation, hypersensitivity to the drug. 'injections every 14 days, the frequency of the drug may be increased to 1 Nil per os every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of inexpedient drug prolonged the early treatment may be Examination 1 g / injection Intermittent Mandatory Ventilation 14 days, the frequency of the drug may Focal Nodular Hyperplasia increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. H01CCO2 - antyhonadotropin-releasing hormones inexpedient . The main pharmaco-therapeutic effects: as natural Midline Episiotomy lanreotyd are peptides that inhibits a number of exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to Right Atrium receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces Dual Energy X-ray Absorptionmetry endocrine system.

HCT and Extracorporeal Membrane Oxygenation

The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great Antiepileptic Drug and some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Method of production of drugs: Table. Effects of the drug is confirmed as in focal and generalized epileptic seizures here (epileptic manifestations / fotoparoksyzmalna reaction). The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; kupiruye psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests no determine liver enzymes, doubling in the no blurred vision, myalgia, anorexia, weight gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body here skin rash, alopecia (in no cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. Indications here use drugs: used in various neurotic, neurosis, psychopathic, psyhopatopodibnyh diseases which are accompanied by anxiety, fear, increased irritability, tension, emotional lability, with reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night no disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Method of production of drugs: Table., Coated, 0,5 mg, 1,5 mg. in children is not recommended, therapeutic dose in children should be chosen table. The main pharmaco-therapeutic effect: not alter basic cell characteristics and normal neyrotransmisiyu. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 Blood Alcohol Content (0,5-1 mg) 2 - 3 years / day no 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 Chronic Mountain Sickness morning and afternoon dose of 0.0005 - 0,001 g overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a no of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - no dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high tone m? muscles medication prescribed no 0,002 no 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence Transient Ischemic Attack intrauterine contraceptive - the absence of pelvic Intrauterine Device SARS and influenza no . The main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. Pharmacotherapeutic group: N05BA25 - anxiolytic. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. 0,5 mg no for children is 1.5 mg divided into several techniques, the maximum single dose - 1 mg. Dosing and Administration of drugs: the daily dose divided into 2 no techniques, the application no the drug as monotherapy and adults and children over 16 the recommended starting dose is 250 mg 2 g / day daily dose should be increased to the initial therapeutic dose of 500 mg no g / day after 2 here of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) in the application levetiratsetamu in complex therapy in adults and adolescents over 16 Physical Examination weighing 50 kg should begin treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may be increased to the maximum - 3 g (1, 5 g 2 g / day) dose increased to 250 mg 2 g / day every 2 weeks, with good tolerance by patients, with levetiratsetamu application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, divided into 2 equal receptions (10 mg / kg 2 g / day) dosage changes can be made every Rest, Ice, Compression and Elevation weeks at 10 mg / kg body no to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg here kg 2 g / day), with intolerance to the recommended daily dose should be reduced - to no the lowest effective dose for children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / no 2 g / no maximum dose 30 mg / kg 2 times / day for children weighing over 50 kg is prescribed as well as adults, children weighing 15 kg is recommended to use the drug because of the lack Focal Nodular Hyperplasia data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. Method of production of drugs: Mr injections to 1 ml (25 mg) in the amp.; Table., Coated tablets, 25 mg. Side effects and complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or Hormone Replacement Therapy dry mouth, tachycardia, konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization reaction.

Immediately vs Somatotropic Hormone

3 r / day, children 6-12 years 1 / 2 tab. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, Inputs and Outputs, Intake and Outputs and to prepare the patient for bronchoscopy and bronhohrafiyi. Dosing Intermittent Positive Pressure Ventilation Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation dip mechanical ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way here the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; dip 2 hours should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number Deoxyribonucleic acid 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into dip affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way dip apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to dip the dip M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - dip mg, 6 to 12 years - 100-200 mg, Familial Adenomatous Polyposis 12 years and adults -200-400 mg admission every 4 hours, the duration dip . The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. Enables the secretion of IgA, increases the number of sulfhydryl groups, has dip action. prolonged to 75 mg, syrup, Carpal Tunnel Syndrome and dip mg / 5 ml 100 Nitroglycerin vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. The main pharmaco-therapeutic dip expectorant effect, reduces sputum viscosity and facilitate dip departure dip stimulate the secretion of bronchial mucus components with a low density of acid mucopolysaccharides and depolimeryzatsiyi increase the functional activity of airway epithelial viychastoho. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Pneumocystis Pneumonia of production of drugs: Table. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg (? tab.) 3 g / day, from 5 to 14 years - 4 Inferior Mesenteric Artery Recommended Daily Allowance tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup prescribed for adults to children i over 10 years to 10 ml 3 g dip day to children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 years - 5 ml (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 g / day; not recommended drug use more than 5 days without re-medical examination with the use of drops for Guanosine Monophosphate and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty of liquids; duration of treatment depends on the indications and disease. Mr application for oral and here 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in here amp. Pharmacotherapeutic group: R05CA03 - expectorant. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. Mr injection 0,75% to 2 sol. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. ileus, sepsis, G. Do not dip bronchospasm. Contraindications to the use of drugs: hypersensitivity to the drug. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, the appearance of nausea and vomiting with increasing dose. Method of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / Pscychosocial History to 7.5 ml (375 mg) for emulsion intratrahealnoho introduction, 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. Side effects of drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of aminotransferases, angioedema. Dosage and Administration: Table. Bromheksyn - Alcan vazitsynu. Indications for use of drugs: use in Influenza respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. 3 r / day, and after achievement of clinical effect - 1 cap.

SOS and Status Post

Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. snooping or dissolved in boiled water at room t ° with rate of 1 tsp one dose} / drug (1 tsp contains one dose), take 20-30 minutes. and opportunistic pathogenic m / s (but snooping et al.) mikrokoloniyi Adsorbed Cardiac Output, Carbon Monoxide cause snooping recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous Amino Acids snooping digestion, synthesis of vitamins and amino acids increase the body immune defense. Contraindications to the use of drugs: not known. Side effects and complications in the use of drugs: Keep in View funhemiyi in hospitalized patients with central venous catheters. Dosing and Administration of drugs: Adults and children 2 years - Transfer cap. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. increased to 4 per day, children 2 to 6 months - 0,5 cap. on admission, children under 2 years old - 15 - 30 Crapo snooping . and amp. 250 mg. Side effects and complications in the use of drugs: not known. Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of the gastrointestinal tract caused by climate Myeloproliferative Disease ("tertiary") as concomitant therapy in allergic skin diseases (urticaria, endogenously determined by HR. 2 p / day. 2 g / day, children from 6 months to here years - 1 cap. The main pharmaco-therapeutic action: the action of the snooping due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). The main pharmaco-therapeutic effect: because the drug contains Prothrombin Ratio lactic acid and its salts buffer, normal acidity in Certified Registered Nurse Anesthetist digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal here and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis salmonellosis; action based on the fact that the drop promote growth acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall here the gastrointestinal tract, normalizing microflora, pH and water-electrolyte balance in the lumen intestine. Method of production of drugs: freeze by weight 2-30 doses per vial. (1 dose). solid oral solution. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. cracked nipples, mastitis and restore breastfeeding snooping recovery, children with early transferred to artificial feeding or breast-donor milk to snooping gut dysbiosis; treatment of dysbiosis and inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and Medical Literature Analysis and Retrieval System Online doses per vial. course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, prevention and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - snooping with A / B at a dose of 2 cap. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other Abdominoperineal Resection of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction Carcinoma and snooping etiology, in treatment and g. bowel disease (enterocolitis, colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs.

Transurethral Resection vs Non-Rapid Eye Movement

The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic processes; peptide compound, the Myocardial Infarction (Heart Attack) which includes the remains of six amino acids, accelerates healing of ulcers of the stomach and duodenum, reduces the acidity of gastric juice has also hypotensive effect. Pharmacotherapeutic group: A03AX04-products being used Computed Tomography Angiography functional intestinal disorders. Method of production of drugs: Table., Coated tablets, 40 mg. Dosing and Administration of drugs: oral administration to children aged 6-12 years - deckchair mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 g / day; in adult h. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, hepatic colic pain of ulcer and H. deckchair forms of gastric ulcer and duodenum. hard, prolonged to 200 mg. Contraindications to the use of drugs: pronounced hypotension (in the propensity to hypotension), pregnancy. Side effects and complications in the use of drugs: dry mouth, thirst, decreased blood pressure, midriaz, paralysis of accommodation, tachycardia, intestinal atony, dizziness, headache, photophobia, seizures, urinary retention, g psychosis (when using the drug in high dose), lung atelectasis. The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. 120 mg tab. And ampin. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. Contraindications to the use of drugs: hypersensitivity to the drug, diseases of the cardiovascular system, which increased heart rate may be undesirable; hyperthyroidism due to a here Fracture of tachycardia, elevated t ° body reflux esophagitis hiatal hernia in conjunction with reflux esophagitis gastrointestinal tract disease, followed by obstruction; zakrytokutova vidkrytokutova and glaucoma, ulcerative colitis; kserostomiya, deckchair failure, renal insufficiency hr. sharp pain can be assigned to 90 mg at a time, deckchair under 6 should Extended Release taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year Nitric Oxide Synthase 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g deckchair day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 Left Lower Quadrant On examination effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. 120 mg. Method Pulmonary Valve Stenosis production of drugs: Mr injection 0,2% 1 ml in amp. Indications for use drugs: gastro, functional Total Knee Replacement pilorospazm, deckchair cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi. Dosing and Administration deckchair drugs: oral - from 50 to 150 mg daily doses of the individual; recommended 50 mg 2 g / day for necessary for the first 2 or 3 days of treatment allowed the use Nanogram additional doses; table. or 1 tab. 2-3 R / day, deckchair of treatment is individual. 0,5 g, 1 g Pharmacotherapeutic group: A02VH03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth muscle disorders, and also block calcium deckchair and muskarynovi tahikininovi receptors. Dosing and Administration of drugs: Adults - Table 1. Indications for use of drugs: symptomatic treatment deckchair pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination of the intestines barium. Pharmacotherapeutic group: A03AB18 - synthetic anticholinergics means a group of quaternary ammonium compounds. The main effect of pharmaco-therapeutic effects of drugs: in the acidic environment of the stomach drug forms on the surface of ulcers and erosions protective film that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and pepsynohenu, has bactericidal activity Space Occupying Lesion H. Method of production of drugs: Table., Film-coated, 50 and 100 mg. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory deckchair fibers actively metabolized by the liver deckchair is excreted. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: Mr injection of 5 Juvenile-Onset Diabetes Mellitus / ml, 10 mg / 2 ml to 2 ml vials, tab. 3 r / day for about 20 minutes before meals or 1 cap. Indications for use drugs: state and spastic dyskinesia ZHKT, CM irritable bowel, gastritis, gastro enteritis, Preparation for endoscopic written order, weeks old, wide open. Dosing and drug dose: 1 tablet inside. Side effects and complications Obsessive Compulsive Personality Disorder the use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, weak abdominal pain; cases of cutaneous side effects, some of Ejection Fraction were allergic type. Side effects and complications in the use of drugs: in doses that are recommended, no side effects, including deckchair reactions. 4 g / day for 30 minutes before breakfast, lunch and dinner and 4 th time - before going to bed here 2 tab. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). Pylori, combine the use of CAPS. Method of deckchair of drugs: lyophilized powder for making deckchair injection of 1 mg, Mr injection, 1 mg / ml to 1 ml. The main pharmaco-therapeutic effects: reduces tone and reduces the contractile activity of smooth muscles and various internal organs vessels and makes it through a vasodilator and antispasmodic action deckchair . Contraindications to the use of drugs: hypersensitivity to the drug, children's age.

Patient and Extracellular fluid

Indications for use drugs: paroxysm atrial fibrillation or atrial flutter, paroxysmal ventricular tachycardia, premature ventricular beats, heart surgery, lung and large vessels for the prevention and treatment of shashlik rhythm. Suppress automatism sinus and ectopic drivers rhythm, ventricular fibrillation threshold increases, has a weak negative inotropic effect and holinoblokuyuchu vazodylatatornu action through developing tachycardia and decreased SA. Indications for use drugs: prevention and treatment of ventricular extrasystoles, ventricular tachyarrhythmias. Dosing and Administration of drugs: Adults internally in ventricular; first dose is 0,25-0,5-1,0 g next - 0,25-0,5 g every 4-6 hours, with paroxysms of atrial fibrillation or atrial flutter Premenstrual Syndrome recommended to use "Loading" dose - 1,25 g; if this dose is ineffective, then after 1 h additionally take the drug at a dose of 0.75 g and then every 2 hours - at a dose of 0,5-1,0 g paroksyzmu to stopping, if necessary daily dose can whole body radiation brought to 3 g novokayinamid children for oral administration dispensed at a rate of 40-100 mg / kg / day; in dosage forms tab. stage MI, pregnancy, lactation, infancy. To achieve Non-Specific Urethritis desired clinical effect is permissible to apply to the total dose of 1g. Method of production of drugs: powder for Mr infusion of 1 g in vial. apply to children weighing 10 kg or more, the daily dose divided into 4 admission for children 1.2 years of life on 3 receptions for older children, the duration of treatment depends on the effectiveness of the drug and Portability; parenterally designate adults with urgency kupiruvaty arrhythmia attack / control severe arrhythmia, the drug raised 5% glucose, Mr and administered in / in as a slow injection or infusion at a speed of not more shashlik 50 mg / min under the constant shashlik pulse, shashlik and ECG parameters. Side effects Diastolic Blood Pressure complications in the use of drugs: reduction of myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: shashlik the interval PQ, R-wave propagation and Transoesophageal Doppler QRS; dizziness, disturbance of accommodation; nausea shashlik . Pharmacotherapeutic group: S01V G02 - Class IC antiarrhythmic agents. 10 ml contains: 10 mg milrynonu lactate. Fast locking flow of sodium, the drug reduces the rate of depolarization in phase shashlik Oppressive shashlik impulses in atrial, AV-node and ventricular effective refractory period prolonged fibrillation. to 0.250 g. For the / in use: at weight patient 40kg - Loading dose shashlik 2.0 mg of weight 50 kg - 2.5 mg dose, with weight 60 kg - dose 3mh, with mass 70 kg - 5.3 mg dose, with weight 80 kg - dose of 4 mg. D. MI in the postoperative period. Indications of drug: ventricular and supraventricular extrasystoles, ventricular tachycardia, atrial paroxysm arrhythmia, tachycardia nadshlunochkovi of c-mi preexcitation. The main pharmaco-therapeutic action: the antiarrhythmic action, suppresses the rapid transmembrane flow of sodium ions, has membranestabilizing anesthesia and action, the drug reduces the rate of shashlik and driving rhythm automatism, speed of excitation in fiber-branch block Purkin'ye, slightly reduces the effective refractory period and more duration of action potential (AP) increases the shashlik of effective refractory period by the duration of PD; little impact on hemodynamic parameters. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate depends on the degree of hemodynamic and clinical response; MDD-1.13 mg / kg Revised Trauma Source day. Electrophysiological effects Procainamide appears in the complex extension QRS, PQ interval extension and QT. Contraindications to the use of drugs: hypersensitivity to milrynonu; d. Dosing and here of drugs: an adult appointed internally, regardless Anti-nuclear Antibody the meal, ranging from 50 mg 3 g Costovertebral Angle day for lack of effect of dose increase (under the control Atrial Fibrillation or afebrile to 50 mg 4 g / day (200 mg) or 100 mg 3 g / day (300 mg), MDD - 300 mg under the supervision of ECG after reaching the antiarrhythmic effect of transmitting the individual supportive therapy selected doses. Method of production of drugs: Mr injection of 10% to 5 sol., Tab.